Prescription medicine
Nadolol First approved as Corgard
Nadolol (Corgard) is a prescription medicine with an FDA approval on record since 1979. FDA's NDC Directory lists it from 16 generic labelers, and pharmacies paid $0.147 per nadolol 20 mg tablet in the October 7, 2026 NADAC survey.
- Generic listed
Check it at the source: the nadolol FDA label on DailyMed (effective May 12, 2026, Amneal Pharmaceuticals NY LLC); the NDA 18063 record on Drugs@FDA; every nadolol label on DailyMed.
Highlights of the record
FDA label of May 12, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usageAngina Pectoris Nadolol tablets are indicated for the long-term management of patients with angina pectoris.
Forms and strengths
- 20 mg
- 40 mg
- 80 mg
Tablet.
On the market
- Earliest approval on file
- December 10, 1979 Corgard, Uswm; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 14 first October 31, 1993; 10 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 16 of which 16 under generic applications, 0 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- $0.147 per tablet Nadolol 20 mg tablet
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- 2 since 2015 0 Class I among all firms' recalls; latest March 15, 2021; 1 more by firms not listed as its makers
- FAERS reports
- 7,532 through July 30, 2026
What is nadolol used for?
From the label: indications and usageAngina Pectoris Nadolol tablets are indicated for the long-term management of patients with angina pectoris. Hypertension Nadolol tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with nadolol tablets. […]
Conditions named in the indications of nadolol's FDA labels, with every medicine labeled for each:
From other nadolol labelsAngina: INDICATIONS AND USAGE Angina Pectoris Nadolol tablets are indicated for the long-term management of patients with angina pectoris.
FDA pharmacologic class: beta-Adrenergic Blocker.
Source: FDA drug label (Nadolol), Amneal Pharmaceuticals NY LLC, effective May 12, 2026 (SPL set e2e24b14-0169-4028-828a-894ad3c2ba55), via openFDA; the full label on DailyMed
Is there a generic for nadolol (Corgard)?
The FDA approved the first generic nadolol on October 31, 1993. 14 generic applications are approved; 10 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists nadolol from 16 labelers under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
- 1979 earliest approval on file
- 1993 first generic approved
- red ticks recalls
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for nadolol (Corgard)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $0.147 per Nadolol 20 mg tablet, up 23% from $0.120 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Nadolol 20 mg tablet (generic)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Nadolol 20 mg tablet | Generic | $0.147 per tablet | $4.40 | +23% |
| Nadolol 40 mg tablet | Generic | $0.265 per tablet | $7.96 | -6% |
| Nadolol 80 mg tablet | Generic | $0.274 per tablet | $8.21 | -4% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
Has nadolol been recalled?
The FDA's Enforcement Report lists 3 recalls naming nadolol since 2015: 0 Class I (the most serious), 3 Class II, 0 Class III; 0 still ongoing. 1 of them is by a firm that FDA's NDC Directory does not list as a maker of nadolol and that holds no application for it in Drugs@FDA, such as compounding pharmacies or bulk-ingredient suppliers; the recall notice names the product recalled. A recall names products and lots, not every product of the medicine.
| Started | Class | Company | Reason |
|---|---|---|---|
| March 15, 2021 | Class II | Cardinal Health Inc. | CGMP Deviations: Intermittent exposure to temperature excursion during storage. |
| December 22, 2016 | Class II | Sandoz Incorporated | Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%) |
| February 12, 2015 | Class II | Health Innovations Pharmacy, Inc not a listed maker | Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures … |
Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026
What does the nadolol label say about other medicines?
The nadolol label names 1 other medicine in its interaction, contraindication or warning sections. The labels of 4 other medicines name nadolol. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Epinephrine | drug interactions | Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. |
Other labels that name nadolol
Source: FDA drug label (Nadolol), Amneal Pharmaceuticals NY LLC, effective May 12, 2026 (SPL set e2e24b14-0169-4028-828a-894ad3c2ba55), via openFDA; the full label on DailyMed
What do FAERS reports show for nadolol?
The FDA Adverse Event Reporting System holds 7,532 reports that list nadolol among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 612 are coded as a death and 2,577 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What else is labeled for the same conditions as nadolol?
24 other medicines are given the same way (oral) and in the same FDA class as nadolol or labeled mainly for the same use (angina), the same class first. Angina lists all 21 medicines labeled for it, by any route. The first 8 are below. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.
| Medicine | Shared indication | Generic labelers (oral) | Pharmacy cost | Shortage |
|---|---|---|---|---|
| Metoprolol | High blood pressure, Angina | 64 labelers | $0.085 per tablet 100 mg tablet | A presentation being discontinued |
| Propranolol | High blood pressure, Angina | 38 labelers | $0.0493 per tablet 20 mg tablet | In shortage |
| Carvedilol | High blood pressure | 41 labelers | $0.0179 per tablet 6.25 mg tablet | No current entry |
| Atenolol | High blood pressure, Angina | 35 labelers | $0.0217 per tablet 25 mg tablet | No current entry |
| Labetalol | High blood pressure | 31 labelers | $0.215 per tablet 300 mg tablet | No current entry |
| Nebivolol | High blood pressure | 23 labelers | $0.141 per tablet 10 mg tablet | A presentation being discontinued |
| Bisoprolol | High blood pressure | 24 labelers | $0.114 per tablet 5 mg tablet | No current entry |
| Bisoprolol and hydrochlorothiazide | High blood pressure | 11 labelers | $0.209 per tablet 10-6.25 mg tablet | No current entry |
Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)
How does nadolol compare with medicines for the same use?
5 side-by-side pages set nadolol beside a medicine whose label shares a use: approvals, generics, pharmacy cost, warnings and supply.
What next?
- Alternatives to nadolol
- 24 medicines for the same use
- Other beta blockers
- the pharmacologic class, with prices and generics
- Nadolol side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other